Literature DB >> 3046644

The place of radiation therapy in the treatment of squamous cell carcinoma of the nasal vestibule. A review.

C S Wong1, B J Cummings.   

Abstract

Radiation therapy and limited resection give equally good results in early squamous cell carcinomas of the nasal vestibule, each producing local control rates of 90% or more. For more extensive disease, primary radiation therapy with surgery reserved for residual or recurrent carcinoma is recommended in view of the significant cosmetic defects which generally follow major resection. Small and superficial lesions can be treated by external beam therapy or interstitial implants. Large or infiltrative lesions are best managed by external beam therapy. Serious late morbidity following irradiation is uncommon and has been reported in fewer than 5% of patients. Regional nodal metastases are diagnosed at the time of first presentation in about 5% of patients and signal a very poor prognosis. However, the data available do not support elective treatment of clinically uninvolved regional nodes. Fewer than 5% of patients manifest late nodal metastases when the primary tumor area remains free of recurrence, and most of these metastases can be controlled by neck dissection and/or irradiation.

Entities:  

Mesh:

Year:  1988        PMID: 3046644     DOI: 10.3109/02841868809093526

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  2 in total

1.  Brachytherapy for primary nasal vestibule cancer using Au-198 grains.

Authors:  Hinako Harada; Yojiro Ishikawa; Shohei Tanaka; Keita Kishida; Rei Umezawa; Takaya Yamamoto; Noriyoshi Takahashi; Kazuya Takeda; Yu Suzuki; Keiichi Jingu
Journal:  Int Cancer Conf J       Date:  2022-04-08

2.  Endonasal resection of early stage squamous cell carcinoma of the nasal vestibule.

Authors:  Georg J Ledderose; Simone Reu; Anna S Englhard; Eike Krause
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-22       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.